Intrexon (NYSE:XON) will post its quarterly earnings results after the market closes on Tuesday, February 27th. Analysts expect Intrexon to post earnings of ($0.32) per share for the quarter.
Intrexon (XON) opened at $13.25 on Tuesday. The company has a market cap of $1,680.00, a price-to-earnings ratio of -11.83 and a beta of 1.40. Intrexon has a 52-week low of $10.26 and a 52-week high of $26.99. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.05 and a quick ratio of 1.85.
In other news, CEO Randal J. Kirk acquired 1,000,000 shares of the firm’s stock in a transaction on Friday, January 19th. The shares were purchased at an average price of $12.50 per share, for a total transaction of $12,500,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 56.30% of the stock is currently owned by insiders.
A number of equities analysts recently commented on the stock. ValuEngine cut shares of Intrexon from a “sell” rating to a “strong sell” rating in a research report on Friday, February 2nd. Zacks Investment Research upgraded shares of Intrexon from a “sell” rating to a “hold” rating in a research report on Monday, January 22nd. Northland Securities reiterated a “buy” rating and issued a $21.00 target price on shares of Intrexon in a research report on Friday, November 10th. Bank of America decreased their target price on shares of Intrexon from $25.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, November 10th. Finally, Stifel Nicolaus lifted their target price on shares of Intrexon from $39.00 to $57.00 and gave the stock a “buy” rating in a research report on Friday, November 10th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company’s stock. Intrexon currently has an average rating of “Hold” and an average price target of $38.50.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright and trademark laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/02/20/intrexon-xon-scheduled-to-post-earnings-on-tuesday.html.
Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.
Receive News & Ratings for Intrexon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon and related companies with MarketBeat.com's FREE daily email newsletter.